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Abstract 
The significant threshold values for the 75g oGTT during pregnancy have yet to be conclusively determined. The study aims 
to identify the risk sign ificance of a borderline oGTT result. Women undergoing a 75g OGTT during the third trimester of 
pregnancy were classified into two groups - borderline tolerance (2-h post-load glucose 8.0-8 .5 mmol/1: n=75), and GDM 
(2:8.6 mmo!/1: n=236). Outcome indicators of these two groups of women were compared to the parameters of the women 
with a presumed nonnal carbohydrate metabolism (n = 12185). GDM women showed themselves to be at a significantly 
increased risk of developing hypertens ive disorders during pregnancy and to require obstetric intervention in the form of 
induction of labour and caesarean section. Their infants were more likely to be macrosomic or preterm and having a low 
Apgar score at birth . Shoulder dystocia was similarl y more likely in infants born to GDM mothers. Women with borderline 
glucose tolerance did not in any way show any statistically significant increased predisposition to these complications. It 
would appear the significant threshold for the 75g oGTT during pregnancy should be of the order proposed by the American 
Diabetes Association criteria where the 2-hour post-load glucose value is 2: 8.6 mmolll. 
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Introduction 
The current classification and diagnostic criteria for 
diabetes mellitm were endorsed by the World . Health 
Organisation in 1980, with modifications in 1985 and 
1994. 1 Controversy however still exists as to what test is 
suitab le for the diagnosis of gestational diabetes, though the 
endorsement of the 75g load by the Fourth International 
Workshop on Gestationa l Diabetes Mel litus [GDM] in 1997 
should have helped break a major stal emate 2 Interpretation 
of the 7 5g oral glucose tolerance test during pregnancy 
remains a contentious issue since the non-pregnant criteria 
ignore the "diabetogenic" physiological changes of 
pregnancy. The current American Diabl .cs Association 
criteria for GDM require two plasma glucose values 2: 5.3 
mmol/1 (fasting) 2: 10.0 mmol/1 (l hour) and 2: 8.6 mmol/1 (2 
hours). 3 The 1994 WHO criteria for gestational diabetes still 
;equired a plasma glucose 2: 7.0 mmol/1 (fasting) or 2: 7.8 
mmol/1 (2 hours). 1 The latter diagnostic criteria ignores the 
physiological changes of pregnancy and thus will inc lude a 
significant proportion of pregnant women whose 
carbohydrate metabolism is normal for their pregnant state. 
The threshold blood glucose leve ls for the development of 
complications associated with GDM have yet to be 
determined. The present study was set up to investigate the 
risk significance of borderline levels of the 2-hour blood 
glucose value after a 75-g oGTT performed in the third 
trimester of pregnancy in a population known to 
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have a high prevalence · of carbohydrate metabolism 
problems, which is reflected in the pregnant population." 
Material & methods 
The study reviewed the medical data records of al l women 
delivering in the Maltese Islands during 1999-200 I [n = 
12540 maternities resulting in 12714 births]. The medical 
records revealed a total of 236 women diagnosed as 
suffering from GDM defined as a 2-h post-75g load glucose 
value of >8.6 mmolll and 75 women suffering from 
borderline glucose tolerance [borderline GT] defined as a 2-
h post-load glucose value of 8.0-8.5 mmol/1. The latter 
group would be considered as suffering from G-lGT by 
WHO criteria. 1 There were in addition 44 ~omen who 
suffered from a pre-existing form of diabetes mellitus [pre-
OM]. Information pertaining to the national incidence of 
congenital malformations was made available from the 
Malta Congenital Anomalies Register for years 1999-2000 
[total infants born = 8759, inclusive 212 infants of women 
with pre-DM and GDM]. During the two-year period no 
cases of congenital malformations were registered in infants 
of women with pre-DM while two cases respectively 
occurred in infants of GDM women. During 2001, a further 
two cases were registered in GDM women and three cases 
in pre-OM women. 
The outcome parameters of the women with GDM and with 
borderline GT were compared to the parameters of women 
with presumed or confirmed normal carbohydrate 
metabolism [n = 12 185]. Glucose to lerance testing is not 
routine ly carried out on all maternities but only in those 
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women who are considered at particular risk of GDM. 5 
During the study period, 6.7% of women [n = 837] were 
thus assessed during the third trimester of pregnancy. 
Comparing the incidence rates from this study to previously 
published prevalence studies,4 it is estimated that about 
31.9% of GDM women are thus identified, while only about 
17.7% of women with a borderline GT are identified. The 
group of patients presumed to have normal carbohydrate 
tolerance thus includes a small proportion of patients with 
mtld degrees of GDM (estimate ~4%: n -'- ~487) and 
borderline GT (estimate ~2.8%: n = ~244). Statistical 
significance was tested using the Chi Square test analysis 
using MedCalc (ver.4.16) statistical package. A probability 
value of <0.05 was taken to represent a significant 
correlation. 
Results 
Women diagnosed as suffering from GDM were more likely 
to have obstetric complications than women with a 
borderline GT and the total population. These complications 
serve to increase the mortality and morbidity of both the 
mother and child [Table 1]. Women with GDM show a 
statistically significant (p<O.OOO 1) increased risk of 
developing hypertensive disease during the pregnancy when 
compared to the normal metabolism population. Women 
with a borderline GT during pregnancy show only a slightly 
increased risk, which did not show statistical significance (p 
= 0.24). The incidence of multiple pregnancies in GDM 
appeared to be increased but the difference did not show 
statistical significance (p = 0.18). The women with 
borderline GT did not show any difference in the multiple 
pregnancy rate (p = 0.63). The pregnancy in the woman 
with GDM was more likely to terminate in an induction of 
labour (p<O.OOOl) and caesarean section (p<O.OOOl). The 
women with a borderline GT did not show any particularly 
statistically significant increased predisposition to induction 
or caesarean section rate. 
Infants of women with GDM showed a statistically 
increased risk of a preterm birth (p = 0.003); of macrosomia 
(p<O.OOOl); of shoulder dystocia (p<O.OOOl); and ofhaving 
a low Apgar score 5 minutes after birth (p = 0.03). No such 
adverse neonatal outcome was noted in infants born to 
women with a borderline glucose tolerance [Table 2]. 
Conclusions 
In 1980 the World Health Organisation suggested that the 
criteria used to diagnose diabetes and IGT in the general 
population could be applied to pregnant women. This view 
was endorsed in 1985 and 1994.1 The 1994 WHO criteria 
for gestational diabetes still required a plasma glucose 2: 7.0 
mmol/1 (fasting) or 2: 7.8 mmol/1 (2 hours). These criteria do 
not take into account the diabetogenic effects of pregnancy. 
Pregnancy causes postprandial blood glucose values to 
remain elevated f0r longer periods of time, hence more 
mothers are likely to exceed any timed postprandial value 
and thus be labeled "glucose intolerant" while only 
displaying the extn:-m~s of physiological adaptation. In 
1989, the Diabetic Pregnancy Study Group (EASD) in a 
multicentt'e European study proposed new higher threshold 
values for the 75-g glucose tolerance test.5 These new 
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thresholds required two plasma glucose values of I 0.5 
mmol/1 (1 hour) and 2: 9.0 mmol/1 (2 hours). Similar 
recommendations were made by the American Diabetes 
Association that require two plasma glucose values of2: 5.3 
mmol/1 (fasting) 2: 10.0 mmol/1 (1 hour) and 2: 8.6 mmol/1 (2 
hours).3 The latter threshold recommendations appear to be 
slowly being universally accepted having been adopted by 
the European Association of Perinatal Medicine.6 
The significance of the relatively physiologically delayed 
response to a 75-g glucose load previously considered 
abnormal by the 1994 WHO diagnostic criteria has still to 
be determined by large-scale clinical studies, particularly 
since studies have shown a continuum of risk related to the 
2-hour maternal post-75g load blood glucose level for the 
probability of having an assisted delivery and the likelihood 
of the baby being admitted to a Special Care Unit, even 
when the 2-hour value was below 8.0 mmol.7 Those with a 
special interest in GDM await the results of the 
Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) 
Study that should determine clear-cut points for the 
complications associated with GDM. 8 The present study has 
confirmed that GDM as defined by the 2-hour value of the 
ADA criteria is associated by a higher maternal morbidity 
in the form of an increased risk of hypertensive disease, and 
more frequent recourse to obstetric intervention. Similarly 
the infants of GDM mothers showed a higher predisposition 
to macrosomia, pretenn births and low Apgar scores. 
Women with borderline glucose tolerance as defined by a 2-
hour post-75g load glucose value of 8.0-8.5 mmol/1 did not 
exhibit any particular increased risk of maternal or fetal 
complications. 
The study thus endorses the ADA diagnostic criteria as 
effective threshold levels to relate to clinical risk status. 
However the outcome indicators assessed in the present 
study reflect short-term complications only. Minor degrees 
of glucose intolerance as reflected by borderline glucose 
tolerance during pregnancy may be attendant by significant 
long-term outcomes in the mother and child. Maltese 
women with a borderline glucose tolerance have been 
shown to be 3.6 times more likely to develop an abnormal 
glucose tolerance eight years postpartum when compared to 
women with a normal glucose tolerance test as defined by 
the WHO criteria.9 The possible effects of relatively 
elevated blood glucose levels on the infant's pancreatic 
development and subsequent adult-onset predisposition to 
develop IGT/NIDDM still need to be investigated. 
Gestational Impaired Glucose Tolerance as defined by the 
1985 WHO criteria has been shown to be associated with 
metabolic changes in the infants that reflect a mild 
derangement to the fetal pancreatic beta cells even though 
the infant's anthropomorphic characteristics were not 
adversely altered. 10 In spite of the apparent absence of 
short-tcnn effects of a borderline glucose tolerance, it may 
remain prudent to continue advising women with a 
borderline glucose tolerance test to reduce their refined 
sugar intake, thus reducing the day-to-day blood glucose 
loads presented to the developing fetus. The long-tenn risks 
to the woman need also be discussed. 
·~ The glucose tolerance test in pregnancy and outcomes 
Table 1: Maternal Complications 
Parameter Normal metabolism GDM Borderline GT 
•!• Multiple births 
•!• Maternal PIH/PET 
•:· Induction of labour 
•!• Caesarean section 
•!• Operative vaginal delivery 
No. 
159 
801 
4398 
2866 
438 
% No. 
1.3 6 
6.6 39 
36.1 127 
23.5 83 
3.9 11 
% p value No. % p value 
2.5 0.18 1 1.3 0.63 
16.5 <0.0001 8 10.7 0.24 
53.8 <0.0001 22 29.3 0.28 
35.2 <0.0001 21 28.0 0.44 
4.7 0.49 1 1.3 0.46 
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Table 2: Infant outcome (*based on 1999-2000 data [total infants= 854 7] ) 
Parameter Nonnal metabolism 
No. % 
•!• Fetal & neonatal loss 118 1.0 
•!• Low birth weight [ <2.5 kg] 768 6.3 
•!• Preterm birth [ <3 7 weeks] 759 6.2 
•!• Infant with RDS 268 2.2 
•!• Macrosomia [>4.0 kg] 732 6.0 
•!• Shoulder dystocia 51 0.4 
•!• Apgar ::; 6 @ 5 min 140 1.1 
•!• Congenital anomalies 316* 3.7 
Total 12274 
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